Clinical Trial Update: Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and quality of life for aflibercept in metastatic colorectal cancer patients previously treated with oxaliplatin-based therapy h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Zaltrap (ramucirumab)

Snippet

Sponsor: Sanofi | Conditions: Colorectal Cancer Metastatic | Phase 3 | Status: COMPLETED | Results posted: 2018-02-27